Springer Medicine

Discover recent advances in pathophysiologic understanding, clinical implications, and recommendations for the management of hospitalized patients with hypopituitarism.

Novel blood-based biomarkers and disease-modifying therapies could revolutionize diagnosis and treatment of Alzheimer’s disease. Are healthcare systems ready?

A pulmonary arterial sarcoma was mistaken as pulmonary vasculitis due to similarities between the diagnoses. But the case highlights some cardinal features of the malignancy that are not seen in vasculitis.

Children with hypertension are at an increased long-term risk for major adverse cardiac events compared with children without hypertension.

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

An expert-led symposium exploring the prevention and management of type 2 diabetes through dietary interventions. Highlights include discussion of the recent EASD guidelines, therapeutic diets, food types and processing, plus psychological factors that influence patient success, and the drivers of healthy eating and diabetes control.

An expert-led symposium exploring the most pertinent issues in cardio-oncology, with a focus on the new ESC guidelines. Highlights include preventative approaches in cardio-oncology, toxicity risk-stratification strategies, the clinical management of myocarditis as an adverse effect of immune checkpoint inhibitor-treatments, and the utility of biomarkers in long-term follow-up of cardiovascular disease risk in cancer patients.